Role of Oxidative Stress Markers and Antioxidants in Diagnosis of Oral Submucous Fibrosis
DOI:
https://doi.org/10.52206/jsmc.2024.14.3.945Abstract
Background: Oral submucous fibrosis is a chronic disease affecting oral cavity. The pathological changes in this disease cause an increase in markers of oxidative stress and decrease in antioxidants. Measuring the levels of these markers in blood can help in
diagnosis of disease.
Objective: To determine the levels of lysyl oxidase, malondialdehyde, superoxide dismutase, catalase and glutathione in patients of oral submucous fibrosis.
Materials and Methods: It was a cross sectional comparative study conducted at Institute of Molecular Biology and Biotechnology, University of Lahore. After the approval of ethical review board, a total of 100 subjects (50 control and 50 patients) were enrolled in the study. Informed written consent was taken from the participants of the study. The levels of lysyl oxidase were measured in the serum samples of patients and were compared with the healthy controls using ELIZA kit (Bio Vendor). Malondialdehyde, superoxide dismutase, catalase and glutathione were measured by spectrophotometric method.
Results: Significantly increasing trends of lysyl oxidase (50.26±10.25pg/ml vs.41.26±5.29pg/ml), MDA (5.65±.065 nmol/ml vs. 1.2±0.956 nmol/ml) and low level of superoxide dismutase, catalase and glutathione were observed in oral submucous fibrosis (0.125±.0956 U/gHb, 1.7±.0259 U/gHb and 1.36±.0325 ìmol/L respectively) in comparison with healthy subjects (0.65±.0156 U/gHb, 4.26±2.056 U/gHb and 10.25±3.29 ìmol/L respectively).
Conclusion: Lysyl oxidase, malondialdehyde, superoxide dismutase, catalase and glutathione can be used as a diagnostic marker of oral submucous fibrosis.
Keywords: Antioxidants, Iysyl oxidase, Malondialdehyde, Oral submucous fibrosis.
References
Mohideen K, Krithika C, Jeddy N, Parveen S, Radhika T, Sankari SL, et al. A Meta-Analysis in Assessing Oxidative Stress Using Malondialdehyde in Oral Submucous Fibrosis. Eur J Dent. 2021;15(4):675. DOI: https://doi.org/10.1055/s-0041-1728230
Shen YW, Shih YH, Fuh LJ, Shieh TM. Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments. Int J Mol Sci. 2020;21(19):119. DOI: https://doi.org/10.3390/ijms21197231
Peng Q, Li H, Chen J, Wang Y, Tang Z. Oral submucous fibrosis in Asian countries. J Oral Pathol Med. 2020;49(4):294-304. DOI: https://doi.org/10.1111/jop.12924
Poornachitra P, Muthukrishnan A, Venugopalan S, Jayasinghe RD, Rajaraman V, Uma TN, et al. Electromyography analysis of the masseter muscle's activity in the management of oral submucous fibrosis. Curçus. 2024;16(5):24. DOI: http://dx.doi.org/10.7759/cureus.59675
Mukherjee S, Katarkar A, Dhariwal R, Mohanty S, Mahato B, Ray JG, et al. Effect of Lysyl Oxidase G473A Polymorphism on Lysyl Oxidase and Total Soluble Collagen Expression in Oral Submucous Fibrosis. Asian Pac J Cancer Prev. 2021;22(8):24-93. DOI: https://doi.org/10.31557/APJCP.2021.22.8.2493
Setargew YFI, Wyllie K, Grant RD, Chitty JL, Cox TR. Targeting lysyl oxidase family meditated matrix Cross-Linking as an Anti-Stromal therapy in solid tumours. Cancers. 2021;13(3):491. DOI: https://doi.org/10.3390/cancers13030491
Ganta S, Chittemsetti S, Sravya T, Guttikonda V. Salivary malondialdehyde in oral submucous fibrosis A marker for oxidative damage. J Oral Maxillofac Pathol. 2021;25(1):82. DOI: https://doi.org/10.4103/jomfp.JOMFP_279_18
Gholami H, Abbasalipourkabir R, Ziamajidi N, Divsalar A, Saeidifar M, Zarei S, et al. The effect of beta-lactoglobulin nanocapsules containing astaxanthin and 5-fluorouracil on the antioxidant enzymes activity of superoxide dismutase, catalase and glutathione peroxidase in HCT116 colorectal cancer cell line. Current Drug Therapy. 2023;18(5):407-14. DOI: https://doi.org/10.2174/1574885518666230403111101
Qin X, Ning Y, Zhou L, Zhu Y. Oral submucous fibrosis: etiological mechanism, malignant transformation, therapeutic approaches and targets. International Journal of Molecular Sciences. 2023;24(5):49-92. DOI: https://doi.org/10.3390/ijms24054992
Rao NR, Villa A, More CB, Jayasinghe RD, Kerr AR, Johnson NW, et al. Oral submucous fibrosis: a contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management. Journal of Otolaryngology-head and Neck Surgery. 2020;49(1):3. DOI: https://doi.org/10.1186/s40463-020-0399-7
Tekin S, Seven E. Assessment of serum catalase, reduced glutathione, and superoxide dismutase activities and malondialdehyde levels in keratoconus patients. Eye.2021;36(10):2062-2066. DOI: https://doi.org/10.1038/s41433-021-01753-1
Min F, Jia X, Gao Q, Niu F, Hu Z, Han Y. Remote ischemic post-conditioning protects against myocardial ischemia/reperfusion injury by inhibiting the Rho-kinase signaling pathway. Exp Ther Med. 2020;19(1)99-106. DOI: https://doi.org/10.3892/etm.2019.8176
Kapgate TD, Bhowate RR, Dangore S, Meshram M, Lohe VK. Effect of turmeric on serum malondialdehyde in oral submucous fibrosis. IJCRR. 2020;12(23):129-35. DOI: https://doi.org/10.31782/IJCRR.2020.122313
Jain A, Kaur G, Ranjan R, Singh D, Porwal D, Shekhawat A. Estimation of serum level of Vitamin A and E in OSMF patients. Int. J. Appl. Dent. 2020; 6(2):174-176DOI: https://www.oraljournal.com/archives/2020/6/2/C/6-2-13
Qin X, Ning Y, Zhou L, Zhu Y. Oral submucous fibrosis: etiological mechanism, malignant transformation, therapeutic approaches and targets. Int. J. Mol. Sci. 2023;24(5):49-92. DOI: https://doi.org/10.3390/ijms24054992
Subramanian VS, Anitha R, Lakshmi T. Assessment of Oxidative stress and Antioxidant Level in Oral Submucous Fibrosis Patients. Int. J. Pharm. Res. 2020;12(4). DOI: https://doi.org/10.31838/ijpr/2020.12.04.635
Sanjeeta N, Banerjee S, Mukherjee S, Devi Tp, Nandini D, Aparnadevi P, et al. Correlation of the activities of antioxidant enzymes superoxide dismutase and glutathione reductase with micronuclei counts among areca nut chewers of Manipuri population using exfoliative cytology: A preliminary study. J. Cancer Ther. 2022;18(4):984. DOI: https://doi.org/10.4103/jcrt.JCRT_1227_20
Shingala A, William A, Thakkar R, Sadek F, Poshiya A. Biochemical estimation of serum malondialdehyde and superoxide dismutase levels in oral submucous fibrosis patients. J Adv Med Dent Scie Res. 2021;9(4):20-3. DOI: https://doi.org/10.21276/jamdsr
Nguyen NH, Tran GB, Nguyen CT. Anti-oxidative effects of superoxide dismutase 3 on inflammatory diseases. J Mol Med. 2020;98(1):59-69. DOI: https://doi.org/10.1007/s00109-019-01845-2
Asantewaa G, Harris IS. Glutathione and its precursors in cancer. Curr Opin Biotechnol. 2021; 68:292-9. DOI: https://doi.org/10.1016/j.copbio.2021.03.001
Banerjee S, Mukherjee S, Mitra S, Singhal P. Comparative Evaluation of Mitochondrial Antioxidants in Oral Potentially Malignant Disorders. Kurume Med J. 2020;66(1):15-27. DOI: https://doi.org/10.2739/kurumemedj.MS661009
Divyambika CV, Sathasivasubramanian S, Vani G, Vanishree AJ, Malathi N. Correlation of Clinical and Histopathological Grades in Oral Submucous Fibrosis Patients with Oxidative Stress Markers in Saliva. Indian J Clin Biochem. 2018;33(3):348-55. DOI: https://doi.org/10.1007/s12291-017-0689-7
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 The authors retain the copyrights. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website), as it can lead to productive exchanges, as well as greater citation of published work.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
